1. Home
  2. ENVX vs MLTX Comparison

ENVX vs MLTX Comparison

Compare ENVX & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$6.93

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$18.07

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVX
MLTX
Founded
2006
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ENVX
MLTX
Price
$6.93
$18.07
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$13.61
$27.50
AVG Volume (30 Days)
5.2M
793.8K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
40.94
N/A
EPS
N/A
N/A
Revenue
$31,821,000.00
N/A
Revenue This Year
$30.37
N/A
Revenue Next Year
$238.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.91
N/A
52 Week Low
$4.67
$5.95
52 Week High
$16.49
$62.75

Technical Indicators

Market Signals
Indicator
ENVX
MLTX
Relative Strength Index (RSI) 58.91 53.86
Support Level $6.68 $15.50
Resistance Level $8.66 $19.16
Average True Range (ATR) 0.44 0.98
MACD -0.00 0.13
Stochastic Oscillator 61.94 40.48

Price Performance

Historical Comparison
ENVX
MLTX

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: